ACON Stock Performance, Insider Transaction and News

ACON - Aclarion, Inc.

Market Cap	5M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-4.91M	Forward P/E	-2.10	EPS next Y	-	50D Avg Chg	-25.00%
Sales	75.4k	PEG	-	EPS past 5Y	-	200D Avg Chg	-20.00%
Dividend	N/A	Price/Book	4.27	EPS next 5Y	-	52W High Chg	-74.00%
Recommedations	2.00	Quick Ratio	0.32	Shares Outstanding	7.15M	52W Low Chg	61.00%
Insider Own	1.93%	ROA	-113.41%	Shares Float	1.93M	Beta	-
Inst Own	0.54%	ROE	-655.74%	Shares Shorted/Prior	61.97K/159.08K	Price	0.61
Gross Margin	-0.43%	Profit Margin	-	Avg. Volume	1,269,870	Target Price	1.50
Oper. Margin	-8,163.67%	Earnings Date	-	Volume	74,640	Change	0.07%

Healthcare | Health Information Services | United States

About Aclarion, Inc.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Aclarion, Inc. News

03/04/24	Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs
02/27/24	Aclarion Announces Closing of $3.0 Million Public Offering
02/26/24	Aclarion Announces Pricing of $3.0 Million Public Offering
02/05/24	Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership
01/29/24	Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?
01/22/24	Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
01/17/24	Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution
01/08/24	Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan
01/02/24	Aclarion Announces Reverse Stock Split
11/27/23	Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams
11/08/23	Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption
11/06/23	Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD
11/01/23	Aclarion Presents at the NIH HEAL Initiative Fall Meeting
10/25/23	Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver
10/24/23	Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting
10/23/23	Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan
10/02/23	Aclarion Provides Updated Investor Presentation and Corporate Update
08/25/23	Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report
06/14/23	Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI
06/08/23	Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

ACON Chatroom

Leopolis Posted - 11 hours ago

$ACON seems like on the horizon is another good pump here

Bullish06 Posted - 14 hours ago

$ACON next week maybe 🤔

AuthenticLiving Posted - 1 day ago

$ACON Aren't you all just so tired of being manipulated by shorts and MMs? Why are we even investing in the US stock market in the companies we believe should raise the capital through our investments so that they can continue to due wonderful things (like heal people, innovate).

AwkumsRaiser Posted - 1 day ago

$ACON This management sucks a bag of elephant cox.

gapureau Posted - 2 days ago

$ACON For clients/investors of Maxim Group LLC, that were offered Units in the IPO of ACON few months ago when stock was about $2-$3, you were probably excited that the Share price (and offering price) "suddenly" dropped to $.58. But, appears someone was not too happy with that scenario... Maybe that is why SP has been Stuck around the $.29-$.33 level. Gl to you but current investors have the chance at almost 100% profit before you break even!!!!

gapureau Posted - 2 days ago

$ACON This has been quit for too long. Been buying last 2 days below $.29. Should have News soon that should give a boost. Still believe Dr. Thramann is looking to sell this company and concentrate on his other much larger potential company $AUUD. IMO Also: $cero, $beat

AwkumsRaiser Posted - 2 days ago

$ACON Calling all Weskruses, calling all Weskruses. Where are you ruse?

Scarface85 Posted - 3 days ago

$ABVC $ACON $GNLN $LGHL Am good here at $LGHL 💎💎💎💎🙏🏼

BobbyBaseball Posted - 3 days ago

$ACON WE NEED NEWS!!! WE NEED MANAGEMENT TO DO THEIR JOB!!

Bossroalkvam Posted - 3 days ago

$ACON https://www.linkedin.com/posts/aclarion_acon-aconw-planetmicrocap-activity-7186058357470855168-JNH8?utm_source=share&utm_medium=member_ios

Bossroalkvam Posted - 3 days ago

$ACON Holding. Not adding before this fucking freak show is over

ASTANA Posted - 4 days ago

$ACON $DYNT

AwkumsRaiser Posted - 4 days ago

$ACON 0.29 is coming. Yeah!

AwkumsRaiser Posted - 4 days ago

$ACON Whoo hoo! Let’s crack 0.30.

user619247 Posted - 1 week ago

$ACON Reailty is that they need doctors to buy into the product...lack of press sounds like no one's putting the money up to support it....and they go broke or dilute by July. GL

AwkumsRaiser Posted - 1 week ago

$ACON LOL. Activity has been so stagnant the crooks are trying to draw retail in by increasing the price.

Bullish06 Posted - 1 week ago

$ACON still accumulating 😁 PT 2.50 $auud reload at 1.50 -2.00 $WAVE I'm back in $NVDA 👀

TickerDD_com Posted - 1 week ago

From 3/28/2024, looking back across 22 Month-Ends for ACON, Percentage Change of Average Monthly Price had More Negatives (59%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ACON #ACON #ACONStock #TickerDD https://www.youtube.com/watch?v=JehBYPXGmMc

ItTakesItAll Posted - 1 week ago

$ACON adding more.

Lucitrades Posted - 1 week ago

$ACON getting really close to a land slide it it falls below $.30

AwkumsRaiser Posted - 1 week ago

$ACON Ok you fuckers in management. Time to chirp. Geezus!

not_enough Posted - 1 week ago

$ACON

Bullish06 Posted - 1 week ago

$ACON Grrr !! News coming soon ?

gapureau Posted - 1 week ago

$ACON Boulder??, Denver, $ACON, $AUUD Both! https://www.cnbc.com/2024/04/08/record-funding-propels-denver-boulders-life-sciences-market.html

zeph1985 Posted - 1 week ago

$ACON in

verns Posted - 1 week ago

@gapureau hey - you seem very knowledgeable about $ACON…I’m considering increasing my investment significantly. My biggest concern is a delisting given current share price and market cap. What are your thoughts on this? Also, how do you know that White Lion isn’t holding anymore shares? And, do you think they were the ones selling to drive the share price down so much? Thanks a lot for any help/guidance you can provide!

Bossroalkvam Posted - 2 weeks ago

$ACON Patience will pay off Holding

Bossroalkvam Posted - 2 weeks ago

$ACON

nbstocks85 Posted - 2 weeks ago

$ACON

Valhalla_77 Posted - 2 weeks ago

$ACON wrong ticker referenced.

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Ness Brent	Chief Executive Offi.. Chief Executive Officer	Dec 28	Buy	0.5	18,500	9,250	19,500	12/29/22
Lorbiecki John Paul	Chief Financial Offi.. Chief Financial Officer	Dec 29	Buy	0.44	22,404	9,858	22,404	12/29/22
Bond Ryan	Chief Strategy Offic.. Chief Strategy Officer	Apr 22	Buy	2.80	20,000	56,000	20,000	04/25/22
Wesemann William	Director Director	Apr 21	Buy	4.35	11,000	47,850	52,736	04/25/22
Ness Brent	Chief Executive Offi.. Chief Executive Officer	Apr 21	Buy	4.35	1,000	4,350	1,000	04/25/22
Neal David K	Director Director	Apr 21	Buy	4.35	34,400	149,640	34,400	04/25/22